Stener-Victorin et al.

BMC Complementary and Alternative Medicine 2013, 13:131

http://www.biomedcentral.com/1472-6882/13/131

RESEARCH ARTICLE

Open Access

Acupuncture and physical exercise for affective

symptoms and health-related quality of life in
polycystic ovary syndrome: secondary analysis
from a randomized controlled trial
Elisabet Stener-Victorin1,2*, Gran Holm3, Per Olof Janson4, Deborah Gustafson5,6 and Margda Waern5

Abstract
Background: Women with polycystic ovary syndrome (PCOS) have symptoms of depression and anxiety and
impaired health related quality of life (HRQoL). Here we test the post-hoc hypothesis that acupuncture and exercise
improve depression and anxiety symptoms and HRQoL in PCOS women.
Methods: Seventy-two PCOS women were randomly assigned to 16 weeks of 1) acupuncture (n = 28); 2) exercise
(n = 29); or 3) no intervention (control) (n = 15). Outcome measures included: change in Montgomery sberg
Depression Rating Scale (MADRS-S), Brief Scale for Anxiety (BSA-S), Swedish Short-Form 36 (SF-36), and PCOS
Questionnaire (PCOSQ) scores from baseline to after 16-week intervention, and to 16-week post-intervention
follow-up.
Results: A reduction in MADRS-S and BSA-S from baseline to 16-weeks post-intervention follow-up was observed
for the acupuncture group. The SF-36 domains role physical, energy/vitality, general health perception and the
mental component of summary scores improved in the acupuncture group after intervention and at follow-up.
Within the exercise group the role physical decreased after treatment, while physical functioning and general
health perception scores increased at follow-up. The emotion domain in the PCOSQ improved after 16-weeks of
intervention within all three groups, and at follow-up in acupuncture and exercise groups. At follow-up,
improvement in the infertility domain was observed within the exercise group.
Conclusion: There was a modest improvement in depression and anxiety scores in women treated with
acupuncture, and improved HRQoL scores were noted in both intervention groups. While not a primary focus of
the trial, these data suggest continued investigation of mental health outcomes in women treated for PCOS.
Trial registration number: ClinicalTrials.gov Identifier: NCT00484705
Keywords: Acupuncture, Anxiety, Depression, Exercise, Health-related quality of life, Polycystic ovary syndrome

Background
Polycystic ovary syndrome (PCOS) is a complex endocrine
and metabolic disorder with an estimated prevalence of 8
18% depending on diagnostic criteria [1]. The characteristics of PCOS include polycystic ovaries, hyperandrogenism,
irregular menstrual cycles, and metabolic abnormalities
* Correspondence: [email protected]
1
Institute of Neuroscience and Physiology, Department of Physiology,
Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
2
Department of Obstetrics and Gynecology, First Affiliated Hospital,
Heilongjiang University of Chinese Medicine, Harbin, China
Full list of author information is available at the end of the article

such as hyperinsulinemia and obesity [2]. PCOS adversely

affects health-related quality of life (HRQoL) [3-5] and
increases risk of depression and anxiety [6-13]. The recent
consensus report on womens health aspects of PCOS
recommended that psychological issues be considered in
all women with PCOS, and highlighted the need for
development of appropriate interventions [14].
The management of PCOS is directed toward improving HRQoL by alleviating co-morbid psychiatric symptoms and preventing long-term physical and psychiatric
complications [4]. First line treatment of women with

2013 Stener-Victorin et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the
Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.

Stener-Victorin et al. BMC Complementary and Alternative Medicine 2013, 13:131

http://www.biomedcentral.com/1472-6882/13/131

PCOS is lifestyle intervention focusing on diet and exercise. In two studies, HRQoL measured by the polycystic
ovary syndrome questionnaire (PCOSQ) improved across
all domains after a lifestyle modification program [15,16].
In obese and overweight PCOS women, diet plus exercise
and diet alone decreased depression scores and improved
the PCOSQ domains of emotion, body weight, and
menstrual problems [17].
Acupuncture with manual stimulation [18,19] and electrical stimulation of low-frequency, i.e. electro-acupuncture
has been shown to be effective in the treatment of major
depression disorder in women without PCOS [20-23], and
in women with depression during pregnancy [24,25] and
post partum [26]. In women with PCOS, both a standardized acupuncture protocol with manual and electrical
stimulation of low-frequency and physical exercise has
been demonstrated to result in more regular menses and
decrease hyperandrogenemia [27]. Whether acupuncture
also improves symptoms of anxiety and depression and/or
HRQoL in these women has not been investigated. In
women with breast cancer, 12 weeks of acupuncture improved HRQoL and sleep assessed with the Womens
Health Questionnaire [28], general well-being assessed with
the Symptom Checklist and mood assessed with the Mood
Scale [29]. Similarly, acupuncture improved HRQoL
assessed by the short-form 36 (SF-36) in patients with
chronic pain conditions, such as dysmenorrhea [30] and
pain from osteoarthritis [31].
Trials of physical exercise for the treatment of depression
suggest that exercise is effective for decreasing depressive
symptoms, although one recent large randomized controlled trials (RCT) reported no significant effect on
depressive symptoms [32,33].
Because PCOS is a chronic disease that is often
accompanied by symptoms of anxiety and depression
and impaired HRQoL, with health implications across
the lifespan, there is a need to evaluate treatment
options that have few negative side effects, such as
acupuncture and physical exercise. In this study, we
tested the secondary hypothesis that affective symptoms
and impaired HRQoL can be improved by acupuncture
and physical exercise in women with PCOS.

Methods
Study design

The study is a secondary analysis of a prospective randomized clinical trial (RCT) [27] in women with PCOS. All
participants were Swedish women living in Gothenburg.
The study was conducted at Sahlgrenska Academy at
the University of Gothenburg, performed in accordance
with Declaration of Helsinki, and approved by the Ethics
Committee at the University of Gothenburg. The Clinical
Trials Government Identifier number is NCT00484705.

Page 2 of 8

All participants gave written informed consent before

entering the study.
Recruitment and participants

PCOS cases were recruited between November 2005

and January 2008 by newspaper advertisements in the
local community. Eligible participants had ultrasoundverified (HDI 5000, ATL, Bothell, WA) polycystic ovaries
with at least 12 follicles 29 mm and/or an ovarian
volume 10 ml in one or both ovaries, together with
oligo/amenorrhea and/or clinical signs of hyperandrogenism. Hyperandrogenism was defined as either;
hirsutism with a Ferriman Gallwey (FG) score 8, and/or
the presence of acne as defined by responding yes to the
question, Do you have acne? together with circulating total
testosterone 1.8 nmol/L [34]. Oligomenorrhea was
defined as an intermenstrual interval >35 days and fewer
than eight menstrual bleedings in the past year.
Amenorrhea was defined as no menstrual bleeding in the
past 90 days.
Exclusion criteria were: age 38 years, any pharmacological treatment for PCOS within 12 weeks of study
entry, or breast feeding within 24 weeks of study entry.
Other exclusion criteria were cardiovascular disease,
type 2 diabetes, and endocrine or neoplastic causes of
hyperandrogenemia, including androgen-secreting tumors, Cushings syndrome, congenital adrenal hyperplasia, and hyperprolactinaemia. In the RCT, women were
randomly allocated in a 2:2:1 ratio to low-frequency EA,
physical exercise, or no active intervention (control). A
2:2:1 ratio was used to facilitate recruitment. To ensure
equal proportions of age and BMI in each study arm,
randomization was stratified by those variables. Within
each stratum, randomization was accomplished by
computer using permuted blocks of 5. Based on the
aforementioned inclusion and exclusion criteria, the final
study population was comprised of 72 PCOS women who
were assessed at baseline, followed by randomization to
acupuncture (n = 28), physical exercise (n = 29), or no
intervention (n = 15) for 16 weeks [27].
Outcome measures

Questionnaires were completed at baseline, after the 16week treatment, and 16 weeks after the last treatment.
The outcome measure assessing symptoms of depression
and anxiety was the CPRS-S-A [35], from which the
subscales Montgomery sberg Depression Rating Scale
(MADRS-S) [36] and the Brief Scale for Anxiety (BSA-S)
[37] were extracted. MADRS-S and BSA-S each include
9 items, of which two are present in both scales. All
items are rated on a 7-point Likert scale, where 0
indicates no symptoms and 6 an extremely pathological
condition. Item ratings are summed, yielding a maximum value of 54 for each scale. A symptom burden

Stener-Victorin et al. BMC Complementary and Alternative Medicine 2013, 13:131

http://www.biomedcentral.com/1472-6882/13/131

of potential clinical relevance was defined as a sum

total 11 on each scale [10].
The outcome measures to assess HRQoL were the
generic SF-36 [38] and the disease-specific Polycystic
Ovary Syndrome Questionnaire (PCOSQ) [39,40]. SF-36
has 36 items, of which 35 are grouped into eight domains: 1) physical function, 2) role physical, 3) role emotional, 4) social functioning, 5) mental health, 6) energy/
vitality, 7) bodily pain, and 8) the experience of change
in general health during the last year. The eight domains
are scored from 0 (worst health) to 100 (best health).
The Swedish version of the PCOSQ has been demonstrated to be valid and reliable [40]. It consists of 26
items grouped into five domains: emotions, body hair,
weight concerns, infertility concerns, and menstrual
irregularities. Each item is rated on a 7-point Likert
scale, from 1 (poorest function) to 7 (optimal function).

Interventions

The acupuncture treatment and physical exercise interventions have been described in detail [27]. In brief, all
participants received general information about the benefits of regular exercise and were instructed to complete
a physical exercise diary during weeks 132 of the study.

Acupuncture intervention

Acupuncture was given twice weekly for 2 weeks, once

weekly for 6 weeks, and once every other week for
8 weeks (14 treatments over 16 weeks). Acupuncture
was performed by a registered physical therapist
educated in theoretical and practical acupuncture skills.
Acupuncture points and electrical stimulation were the
same for all women in the acupuncture group. Disposable, single-use, sterilized stainless-steel needles (Hegu
Xeno, Hegu, Landsbro, Sweden; length 30/50 mm, diameter 0.32 mm) were inserted to a depth of 1535 mm in
four acupuncture points in abdominal muscles and four
in the muscles below the knee, bilaterally. All points in
somatic segments corresponded to the innervation of
the ovaries (Th12L2, S2S4). Two needles were also
placed in extrasegmental acupuncture points that do not
innervate the ovaries (muscles in the hand and lower
arm, bilaterally) to enhance central nervous system
effects. All needles were stimulated manually once when
inserted. During each treatment, needles in abdominal
and leg muscles were stimulated electrically with lowfrequency (2 Hz) (CEFAR ACUS 4, Cefar-Compex
Scandinavia, Malm, Sweden) for 30 min. The intensity
was adjusted to produce local muscle contractions
without pain or discomfort. Needles in the hand/lower
arm were stimulated manually by rotating the needle to
evoke needle sensation every 10 min.

Page 3 of 8

Physical exercise intervention

The physical exercise program consisted of 16 weeks of

regular exercise, including brisk walking, cycling, or any
other aerobic exercise at a self-selected pace described
as faster than normal walking that could be sustained
for at least 30 min at least 3 days per week according to
the protocol by Randeva et al. [41]. Physical exercise
was self-monitored with a heart rate monitor (ECG2,
Sports Instruments, US) to ensure a heart rate 120
beats/min. After the initial instructions of exercise,
participants did not receive any direct contact with the
investigators except that they were supervised through
weekly telephone calls to provide guidance on how to
increase physical exercise. All exercise was in addition
to usual daily physical activity.
Controls

Like the other participants, women in the no intervention group received oral information about the benefits
of regular physical exercise. All participants could call
the study coordinator at any time.
Statistical analyses

Values are presented as mean SD. All scores were

treated as ordinal variables and assessed with nonparametric statistical tests. Sample size calculations for the
RCT have been described previously [27]. Data were
analyzed according to the intention to treat principle.
Missing data were replaced by carrying forward the last
observation to evaluate changes over baseline to after
16-week intervention, and to 16-week post-intervention
follow-up i.e. 32 weeks.
Between group differences in MADRS-S, BSA-S, SF-36
and PCOSQ scores from baseline to after 16-week intervention, and to 16-week post-intervention follow-up were
analyzed with the Kruskal-Wallis test followed by the
MannWhitney U test. Potential within group changes
(baseline versus week 16 and baseline versus week 32)
were analyzed with the Wilcoxon signed-rank test.
IBM SPSS Statistics version 19 for Windows (SPSS,
Chicago, IL) was used for statistical analyses; P < 0.05
(two-sided) was considered statistically significant.

Results
Table 1 shows anthropometry and scores on PCOSQ
domains for all participants. There were no differences
in anthropometric measurements before and after
treatment, as reported [27].
Symptoms of depression and anxiety. There were no
baseline differences between the groups regarding
anxiety and depression scores; MADRS-S and BSA-S
(Table 2). Over the 16 week intervention, there was
neither within group differences nor between group
differences regarding change in MADRS-S or BSA-S

Stener-Victorin et al. BMC Complementary and Alternative Medicine 2013, 13:131

http://www.biomedcentral.com/1472-6882/13/131

Table 1 Anthropometry and PCOSQ domains of women

with polycystic ovary syndrome
PCOS (n = 72)
Anthropometry
Age (years)

29.9 4.4

BMI (kg/m )

28.1 7.4

WHR

0.84 0.07

PCOSQ
Emotions

4.4 1.2

Body hair

3.4 2.0

Body weight

3.6 2.0

Infertility

4.0 1.7

Menstruation

4.0 1.1

Values are mean SD. BMI, body mass index; WHR, waist hip ratio; PCOSQ,
polycystic ovary syndrome questionnaire.

scores (Table 3). At week 32, the MADRS-S score was

significantly lower in the acupuncture group (Table 4).
No change was observed between baseline and week 32
in MADRS score was observed in the exercise group at
week 32. The BSA-S score was significantly lower within
the acupuncture group at week 32 and differed from that
in the exercise group but not the control group (Table 4).
Although there was no within group change in the

Page 4 of 8

exercise group, the BSA-S score differed from that in the

control group at week 32 (Table 4).
HRQoL. There were no baseline differences between
the groups regarding HRQoL; SF-36 and PCOSQ scores
(Table 2). Between baseline and week 16, the SF-36
domain role physical score increased within the acupuncture group and the delta change differed from that in the
exercise group which had decreased but not the control
group (Table 3). The SF-36 domains social functioning,
energy/vitality, general health perception and the mental
component summary score increased within the acupuncture group between baseline and week 16, although
there were no between group differences. Between baseline and follow up, the SF-36 domains role physical,
energy/vitality, general health perception and the mental
component summary score increased within the
acupuncture group, with no between group differences
(Table 4).
Within the physical exercise group the physical functioning score was higher at week 32 compared to baseline,
and delta change differed from that in the acupuncture
and control groups (Table 4). The general health perception score increased within the exercise intervention
group. Within the control group, role emotional score was
greater at week 32 compared to baseline.

Table 2 Baseline characteristics

Acupuncture (n = 28)

Physical exercise (n = 29)

Control (n = 15)

P Between group

Depression & Anxiety scores

MADRS-S sum total

10.7 6.2

10.8 9.0

13.8 9.4

ns

BSA-S sum total

13.1 6.4

11.3 6.0

14.6 5.7

ns

Physical functioning

88.6 16.4

87.9 15.0

92.3 10.0

ns

Role physical

67.9 33.9

86.2 22.7

76.7 30.6

ns

Role emotional

52.4 43.9

47.1 42.3

37.8 41.5

ns

Social functioning

74.6 21.6

67.2 26.2

67.5 31.3

ns

Mental health

60.3 19.5

60.3 19.9

56.0 23.1

ns

Energy/vitality

44.3 22.0

48.8 23.9

46.6 19.2

ns

Bodily pain

73.4 19.4

71.9 32.6

72.9 23.5

ns

General health perception

56.6 25.2

63.7 18.0

64.6 18.6

ns

Physical component summary

50.1 9.8

53.1 7.4

54.4 6.1

ns

Mental component summary

35.7 14.2

33.8 12.9

30.8 15.2

ns

Emotions

4.7 1.2

4.2 1.1

4.2 1.2

ns

Body hair

4.0 2.2

2.9 1.9

3.3 1.9

ns

Body weight

4.1 2.2

3.3 2.0

3.1 1.7

ns

Infertility

4.2 1.7

3.6 1.6

4.5 1.6

ns

Menstruation

4.1 0.9

3.9 1.2

4.0 1.4

ns

SF36 domains

SF36 summary scores

PCOSQ

Values are mean SD. Between-group differences at baseline were determined with the Kruskal-Wallis test.

Stener-Victorin et al. BMC Complementary and Alternative Medicine 2013, 13:131

http://www.biomedcentral.com/1472-6882/13/131

Page 5 of 8

Table 3 Changes in outcome measures from baseline to week 16 directly after treatment
Acupuncture (n = 28)

Physical exercise (n = 29)

Mean SD

Mean SD

MADRS-S sum total

0.96 5.25

9.0

0.52 7.62

BSA-S sum total

1.61 4.72

12.3

0.41 5.62

1.7 12.9

1.9

0.9 10.2

P*

Control (n = 15)
Mean SD

4.8

1.53 5.33

11.1

ns

3.6

0.13 3.96

0.9

ns

1.0

4.0 8.1

4.3

ns

Depression & Anxiety scores

SF-36 domains
Physical functioning
Role physical

8.0 31.2

11.8

16.4 36.8

19.0

6.7 27.5

8.7

0.046

Role emotional

6.5 35.8

12.4

5.7 45.5

12.1

15.6 35.3

41.3

ns

10.7

3.0 23.1

4.5

3.3 18.0

4.9

ns

9.5

1.1 19.8

1.8

4.5 13.7

8.0

ns

19.0

0.7 16.8

1.4

1.2 16.4

2.6

ns

3.0

1.3 30.2

1.8

3.0 19.7

4.1

ns

10.4

1.2 11.6

1.9

5.5 16.8

8.5

ns

A,a

Social functioning

8.0 17.7

Mental health

5.7 16.0

Energy/vitality

8.4 16.9

Bodily pain

2.2 21.2

General health perception

5.9 13.6

SF-36 summary scores

Physical component

0.4 6.4

0.8

1.6 6.2

3.0

3.2 4.6

5.9

ns

Mental component

4.3 9.7b

12.0

1.6 10.5

4.7

1.5 9.2

4.9

ns

Emotions

0.8 0.8c

17.0

0.8 1.2e

19.0

0.7 0.7g

16.7

ns

Body hair

0.1 0.8

2.5

0.1 0.6

3.4

0.2 1.1

Body weight

0.2 0.5

4.9

0.1 1.1

3.0

0.6 1.0

Infertility

0.3 1.0

7.1

0.4 1.0d

11.1

Menstruation

0.4 1.0

9.8

0.4 1.0

10.3

PCOSQ domains

6.1

ns

19.4

ns

0.0 0.7

0.0

ns

0.4 0.8f

10.0

ns

*Intergroup differences for the changes from baseline to week 16 were determined by the Kruskal-Wallis test followed by MannWhitney U-test: P < 0.05 vs
physical exercise. Within group changes were determined by Wilcoxon rank-sum test: aP < 0.05 (acupuncture group); bP < 0.01 (acupuncture group); cP < 0.001
(acupuncture group); dP < 0.05 (exercise group); eP < 0.001 (exercise group); fP < 0.05 (control group); gP < 0.001 (control group).

There were no between group differences on delta

change between baseline and week 16 in any of the five
PCOSQ domains (Table 3). The emotions domain increased significantly within all three groups between
baseline and week 16; the infertility domain increased
within the exercise group, and the body weight and
menstruation domains increased within the control
group (Table 3).
At 32 week follow-up, improvement in the infertility
domain was observed within the exercise group and
delta change differed from that in the control group
(Table 4). The emotion domain was higher at week 32
compared to baseline within the acupuncture and
exercise groups, and the body weight domain was higher
in the control group at week 32 compared to baseline.

Discussion
This is the first study to evaluate the effect of acupuncture
on affective symptoms and HRQoL in women with PCOS.
We demonstrated a within group reduction in depression
and anxiety scores at follow up 16 weeks after the last
treatment. HRQoL was greater in the acupuncture group,
as reflected by increased scores in the SF-36 domain role

physical after a 16 week intervention. In addition, the SF36 domains social functioning, energy/vitality, and general
health perception and the mental component of SF-36
summary scores improved within the acupuncture group
although there were no between-group differences. The
effect remained at 32 weeks follow-up in the domain roles
physical, energy/vitality, and general health perception and
in the mental component of SF-36 summary scores. The
emotion domain in the PCOSQ also improved significantly after the 16 week acupuncture intervention, which
persisted at 32 weeks.
The results in the present study are in line with previous
reports indicating that acupuncture can reduce symptoms
of anxiety [42] and depression [22,23,25] and improve
HRQoL [28,30,31] in other conditions than PCOS. The
effect of acupuncture was more pronounced on anxiety
symptoms and there was a clear tendency of decrease
within the acupuncture group immediately after the treatment period but it did not reach statistical significance. At
the follow up, the decrease was even larger and decreased
symptoms of anxiety as compared to the exercise group.
This may reflect that the effect of treatment last at least
4 months after the treatment period.

Stener-Victorin et al. BMC Complementary and Alternative Medicine 2013, 13:131

http://www.biomedcentral.com/1472-6882/13/131

Page 6 of 8

Table 4 Changes in outcome measures from baseline to follow-up week 32

Outcome measure

Acupuncture (n = 28)

Physical exercise (n = 29)

P*

Control (n = 15)

Mean SD

Mean SD

Mean SD

MADRS-S sum total

1.00 8.07 a

9.3

0.55 8.00

5.1

1.00 6.94

7.2

ns

BSA-S sum total

1.74 7.88 A,a

13.3

1.41 6.86 B

12.5

1.53 3.78

10.5

0.027

2.5 17.4

2.8

3.8 6.7

4.3

3.7 7.4

4.0

0.008

Depression & Anxiety scores

SF-36 domains
Physical functioning

C,d

Role physical

12.5 33.7

18.4

0.9 19.5

1.0

6.7 27.5

8.7

ns

Role emotional

11.9 40.8

22.7

17.2 42.4

36.5

22.2 34.9 f

58.7

ns

Social functioning

5.8 20.5

7.8

5.2 25.3

7.7

2.5 21.2

3.7

ns

Mental health

6.3 19.5

10.4

4.1 20.0

6.8

4.3 21.9

7.7

ns

Energy/vitality

11.3 17.0

25.5

5.5 20.5

11.3

4.2 18.3

9.0

ns

Bodily pain

2.8 20.6

3.8

3.6 30.0

5.0

0.3 15.8

0.4

ns

General health perceptions

6.8 16.0a

12.0

5.3 10.0 c

8.3

4.6 19.2

7.1

ns

SF-36 summary scores

Physical component summary

0.5 7.9

1.0

0.2 5.2

0.4

1.7 5.1

3.1

ns

Mental component summary

5.1 12.4a

14.3

4.3 11.6

12.7

1.8 11.6

5.8

ns

Emotions

0.4 0.8a

8.5

0.6 1.0

14.3

0.1 0.7

2.4

ns

Body hair

0.1 0.9

2.5

0.1 0.8

3.4

0.2 0.8

6.1

ns

Body weight

0.2 0.8

4.9

0.2 1.2

6.1

0.4 0.8

12.9

ns

16.7

0.1 0.8

2.2

0.014

2.6

0.5 1.0

12.5

ns

PCOSQ domains
d

B,d

Infertility

0.2 1.1

4.8

0.6 1.2

Menstruation

0.3 1.0

7.3

0.1 1.0

*Intergroup differences for the changes from baseline to week 16 were determined by the Kruskal-Wallis test followed by MannWhitney U-test: P < 0.05 vs
physical exercise; BP < 0.05 vs control group; CP < 0.05 vs EA and control group. Within group changes were determined by Wilcoxon rank-sum test: aP < 0.05
(acupuncture group); bP < 0.01 (acupuncture group); cP < 0.05 (exercise group); dP < 0.01 (exercise group); eP < 0.001 (exercise group); fP < 0.05 (control group).

The acupuncture protocol used in the present study

was designed to improve reproductive and endocrine
function. Accordingly, needles were placed in abdominal
and leg muscles with the same innervation as the ovaries. Additionally two points, one in each hand was
placed. Points in arm/hand and leg/feet are considered
to have a strong input to central nervous system [43]. If
the primary aim of this study would have been to elucidate the efficacy of acupuncture on symptoms of anxiety
and depression and HRQoL, the acupuncture protocol
would have been the same but with additional points in
the head, e.g. EX1 and GV20 and stimulated electrically
since these points has been shown to relive symptoms of
depression [22,23,25].
There was no effect on symptoms of anxiety and depression in the exercise group, while the SF-36 domain
physical functioning score and the PCOSQ domain
infertility improved at the 16-week follow-up compared
with the control group. Directly after the treatment
period, the exercise group improved in the PCOSQ domains emotion and infertility scores. The improvement
in the infertility score in the exercise group may reflect
an effect on menstrual function. In the primary study

[27], the menstrual function was increased both after the

treatment and at follow up which most likely reflect
improved infertility score on PCOSQ.
A lifestyle program, including dietary intervention
leading to considerable weight loss, has been shown to
induce major improvement in HRQoL in patients with
type 2 diabetes, and the addition of exercise was important for maintaining better HRQoL [44]. However, studies
of lifestyle intervention in women with PCOS have not
shown that exercise reduces symptoms of anxiety and
depression and HRQoL beyond the reductions observed
after dietary intervention and weight loss [15,17].
Evidently, weight loss is an important predictor of improvement in affective symptoms and HRQoL. However,
the effect on HRQoL in the current study cannot be
attributed to weight reduction as there were no changes
in weight or BMI [27].
A recent systematic review found strong evidence that
exercise reduces depressive symptoms among patients
with chronic illness [45]. However, recently a large RCT
including 361 adults with symptoms of depression found
no effect of physical activity including three face to face
sessions and 10 telephone calls over eight months [33].

Stener-Victorin et al. BMC Complementary and Alternative Medicine 2013, 13:131

http://www.biomedcentral.com/1472-6882/13/131

The relatively weak response in the exercise group in the

present study may reflect that exercise was self-directed
but with telephone support. Again, these findings indicate
the need for further research on the effects of exercise in
women with PCOS. Structured, supervised exercise
may improve affective symptoms and HRQoL and is
recommended in future studies.
The PCOSQ domains, emotions, body weight, and
menstruation were higher in the control group after
treatment, and the body weight domain persisted higher
at the week 32 follow-up. These results suggest that
merely entering a study and being examined is positive.
Importantly, information on the benefits of regular
physical exercise and information about their condition
that may have made them feel less different and/or
increased their understanding of their health concerns,
was provided to all women at the baseline visit.
Methodological considerations

A strength of this study is the randomized design. However, it was also limited by the multiple comparisons and
characteristics of the study design, as extensively discussed
elsewhere [27,46]. Importantly, the results presented in
this paper stem from a secondary analysis; the study was
not designed or powered to specifically address these
research questions. We suggest that future RCTs for
women with PCOS include assessments of anxiety and
depression symptoms and HRQoL to elucidate the impact
of any intervention on these variables.

Conclusions
In conclusion, there was a modest improvement in
depression and anxiety scores in women treated with
acupuncture, and improved HRQoL scores were noted
in both intervention groups. Acupuncture and physical
exercise are well-tolerated and safe. While not a primary
focus of the clinical trial, these data suggest continued
investigation of mental health outcomes in women
treated for PCOS.
Competing interests
The authors have nothing to disclose and no competing financial interest exist.

Authors contributions
Conceived and designed the trial: ESV, GH, and POJ. Performed the trial: ESV,
GH, and POJ. Analyzed the data: ESV, MW, and DG. Manuscript drafting and
critical discussion: ESV, GH, POJ, DG, and MW. All authors read and approved
the final manuscript.

Acknowledgement
We thank Elizabeth Jedel for carrying out the clinical trial and Professor
Anders Odn for excellent statistical advice. The study was supported by
grants from the Swedish Medical Research Council (K2012-55X-15276-08-3),
the Swedish Federal Government under the LUA/ALF (ALFGBG-136481), and
the Regional Research and Development agreement (VGFOUREG-5171, 11296, and 7861). No competing interest declared.

Page 7 of 8

Author details
1
Institute of Neuroscience and Physiology, Department of Physiology,
Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
2
Department of Obstetrics and Gynecology, First Affiliated Hospital,
Heilongjiang University of Chinese Medicine, Harbin, China. 3Institute of
Medicine, Department of Metabolism and Cardiovascular Research,
Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
4
Institute of Clinical Science, Department of Obstetrics and Gynaecology,
Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
5
Institute of Neuroscience and Physiology, Department of Psychiatry and
Neurochemistry, Sahlgrenska Academy, University of Gothenburg,
Gothenburg, Sweden. 6State University of New York Downstate Medical
Center, Brooklyn, NY, USA.
Received: 7 February 2013 Accepted: 11 June 2013
Published: 13 June 2013
References
1. March WA, Moore VM, Willson KJ, Phillips DI, Norman RJ, Davies MJ: The
prevalence of polycystic ovary syndrome in a community sample
assessed under contrasting diagnostic criteria. Hum Reprod 2010,
25(2):544551.
2. Norman RJ, Dewailly D, Legro RS, Hickey TE: Polycystic ovary syndrome.
Lancet 2007, 370(9588):685697.
3. Barnard L, Ferriday D, Guenther N, Strauss B, Balen AH, Dye L: Quality of life
and psychological well being in polycystic ovary syndrome. Hum Reprod
2007, 22(8):22792286.
4. Jones GL, Hall JM, Balen AH, Ledger WL: Health-related quality of life
measurement in women with polycystic ovary syndrome: a systematic
review. Hum Reprod Update 2008, 14(1):1525.
5. Tan S, Hahn S, Benson S, Janssen OE, Dietz T, Kimmig R, Hesse-Hussain J,
Mann K, Schedlowski M, Arck PC, et al: Psychological implications of
infertility in women with polycystic ovary syndrome. Hum Reprod 2008,
23(9):20642071.
6. Adali E, Yildizhan R, Kurdoglu M, Kolusari A, Edirne T, Sahin HG, Yildizhan B,
Kamaci M: The relationship between clinico-biochemical characteristics
and psychiatric distress in young women with polycystic ovary
syndrome. J Int Med Res 2008, 36(6):11881196.
7. Bhattacharya SM, Jha A: Prevalence and risk of depressive disorders in
women with polycystic ovary syndrome (PCOS). Fertil Steril 2010,
94(1):357359.
8. Deeks AA, Gibson-Helm ME, Teede HJ: Anxiety and depression in
polycystic ovary syndrome: a comprehensive investigation. Fertil Steril
2010, 93(7):24212423.
9. Hollinrake E, Abreu A, Maifeld M, Van Voorhis BJ, Dokras A: Increased risk of
depressive disorders in women with polycystic ovary syndrome.
Fertil Steril 2007, 87(6):13691376.
10. Jedel E, Waern M, Gustafson D, Landen M, Eriksson E, Holm G, Nilsson L,
Lind AK, Janson PO, Stener-Victorin E: Anxiety and depression symptoms
in women with polycystic ovary syndrome compared with controls
matched for body mass index. Hum Reprod 2010, 25(2):450456.
11. Kerchner A, Lester W, Stuart SP, Dokras A: Risk of depression and other
mental health disorders in women with polycystic ovary syndrome: a
longitudinal study. Fertil Steril 2009, 91(1):207212.
12. Mansson M, Holte J, Landin-Wilhelmsen K, Dahlgren E, Johansson A, Landen
M: Women with polycystic ovary syndrome are often depressed or
anxious-A case control study. Psychoneuroendocrinology 2008,
33(8):11321138.
13. Pastore LM, Patrie JT, Morris WL, Dalal P, Bray MJ: Depression symptoms
and body dissatisfaction association among polycystic ovary syndrome
women. J Psychosom Res 2011, 71(4):270276.
14. Fauser BC, Tarlatzis BC, Rebar RW, Legro RS, Balen AH, Lobo R, Carmina E,
Chang J, Yildiz BO, Laven JS, et al: Consensus on womens health aspects
of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRMSponsored 3rd PCOS Consensus Workshop Group. Fertil Steril 2012,
97(1):2838 e25.
15. Harris-Glocker M, Davidson K, Kochman L, Guzick D, Hoeger K:
Improvement in quality-of-life questionnaire measures in obese
adolescent females with polycystic ovary syndrome treated with lifestyle
changes and oral contraceptives, with or without metformin. Fertil Steril
2010, 93(3):10161019.

Stener-Victorin et al. BMC Complementary and Alternative Medicine 2013, 13:131

http://www.biomedcentral.com/1472-6882/13/131

16. Palomba S, Giallauria F, Falbo A, Russo T, Oppedisano R, Tolino A, Colao A,

Vigorito C, Zullo F, Orio F: Structured exercise training programme versus
hypocaloric hyperproteic diet in obese polycystic ovary syndrome
patients with anovulatory infertility: a 24-week pilot study. Hum Reprod
2008, 23(3):642650.
17. Thomson RL, Buckley JD, Lim SS, Noakes M, Clifton PM, Norman RJ,
Brinkworth GD: Lifestyle management improves quality of life and
depression in overweight and obese women with polycystic ovary
syndrome. Fertil Steril 2010, 94(5):18121816.
18. Allen JJ, Schnyer RN, Chambers AS, Hitt SK, Moreno FA, Manber R:
Acupuncture for depression: a randomized controlled trial.
J Clin Psychiatry 2006, 67(11):16651673.
19. Roschke J, Wolf C, Muller MJ, Wagner P, Mann K, Grozinger M, Bech S: The
benefit from whole body acupuncture in major depression. J Affect
Disord 2000, 57(13):7381.
20. Luo H, Meng F, Jia Y, Zhao X: Clinical research on the therapeutic effect
of the electro-acupuncture treatment in patients with depression.
Psychiatry Clin Neurosci 1998, 52(Suppl):S338S340.
21. Luo HC, Jia YK, Li Z: Electro-acupuncture vs. amitriptyline in the
treatment of depressive states. J Tradit Chin Med 1985, 5(1):38.
22. Yeung WF, Chung KF, Tso KC, Zhang SP, Zhang ZJ, Ho LM:
Electroacupuncture for residual insomnia associated with major depressive
disorder: a randomized controlled trial. Sleep 2011, 34(6):807815.
23. Gronier H, Letombe B, Collier F, Dewailly D, Robin G: Focus on intrauterine
contraception in 15 questions and answers. Gynecol Obstet Fertil 2012,
40(1):3742.
24. Manber R, Schnyer RN, Allen JJ, Rush AJ, Blasey CM: Acupuncture: a
promising treatment for depression during pregnancy. J Affect Disord
2004, 83(1):8995.
25. Manber R, Schnyer RN, Lyell D, Chambers AS, Caughey AB, Druzin M, Carlyle
E, Celio C, Gress JL, Huang MI, et al: Acupuncture for depression during
pregnancy: a randomized controlled trial. Obstet Gynecol 2010,
115(3):511520.
26. Hardy OT, Wiecha J, Kim A, Salas C, Briceno R, Moody K, Becker J, Glazer G,
Ciccarelli C, Shi L, et al: Effects of a multicomponent wellness intervention
on dyslipidemia among overweight adolescents. Journal of pediatric
endocrinology & metabolism: JPEM 2012, 25(12):7982.
27. Jedel E, Labrie F, Oden A, Holm G, Nilsson L, Janson PO, Lind AK, Ohlsson C,
Stener-Victorin E: Impact of electro-acupuncture and physical exercise on
hyperandrogenism and oligo/amenorrhea in women with polycystic
ovary syndrome: a randomized controlled trial. Am J Physiol Endocrinol
Metab 2011, 300(1):E37E45.
28. Frisk J, Kallstrom AC, Wall N, Fredrikson M, Hammar M: Acupuncture
improves health-related quality-of-life (HRQoL) and sleep in women with
breast cancer and hot flushes. Support Care Cancer 2012, 20(4):715724.
29. Nedstrand E, Wyon Y, Hammar M, Wijma K: Psychological well-being
improves in women with breast cancer after treatment with applied
relaxation or electro-acupuncture for vasomotor symptom. J Psychosom
Obstet Gynaecol 2006, 27(4):193199.
30. Witt CM, Reinhold T, Brinkhaus B, Roll S, Jena S, Willich SN: Acupuncture in
patients with dysmenorrhea: a randomized study on clinical
effectiveness and cost-effectiveness in usual care. Am J Obstet Gynecol
2008, 198(2):166e161-168.
31. Witt CM, Jena S, Brinkhaus B, Liecker B, Wegscheider K, Willich SN:
Acupuncture in patients with osteoarthritis of the knee or hip: a
randomized, controlled trial with an additional nonrandomized arm.
Arthritis Rheum 2006, 54(11):34853493.
32. Sybulski S: Testosterone metabolism by rat placenta. Steroids 1969,
14(4):427440.
33. Crisosto N, Echiburu B, Maliqueo M, Perez V, LadrondeGuevara A, Preisler J,
Sanchez F, Sir-Petermann T: Improvement of hyperandrogenism and
hyperinsulinemia during pregnancy in women with polycystic ovary
syndrome: possible effect in the ovarian follicular mass of their
daughters. Fertil Steril 2012, 97(1):218224.
34. Stener-Victorin E, Holm G, Labrie F, Nilsson L, Janson PO, Ohlsson C: Are
there any sensitive and specific sex steroid markers for polycystic ovary
syndrome? J Clin Endocrinol Metab 2010, 95(2):810819.
35. Svanborg P, Asberg M: A new self-rating scale for depression and anxiety
states based on the Comprehensive Psychopathological Rating Scale.
Acta Psychiatr Scand 1994, 89(1):2128.

Page 8 of 8

36. Montgomery SA, Asberg M: A new depression scale designed to be

sensitive to change. Br J Psychiatry 1979, 134:382389.
37. Tyrer P, Owen RT, Cicchetti DV: The brief scale for anxiety: a subdivision of
the comprehensive psychopathological rating scale. J Neurol Neurosurg
Psychiatry 1984, 47(9):970975.
38. Sullivan M, Karlsson J, Taft C: H: Svensk Manual och Tolkningsguide, 2:a
upplagan [Swedish interpretation guide, 2nd edition]. Gothenburg:
Sahlgrenska University Hospital; 2002. (in Swedish). 2002.
39. Cronin L, Guyatt G, Griffith L, Wong E, Azziz R, Futterweit W, Cook D, Dunaif
A: Development of a health-related quality-of-life questionnaire (PCOSQ)
for women with polycystic ovary syndrome (PCOS). J Clin Endocrinol
Metab 1998, 83(6):19761987.
40. Jedel E, Kowalski J, Stener-Victorin E: Assessment of health-related quality
of life: Swedish version of polycystic ovary syndrome questionnaire.
Acta Obstet Gynecol Scand 2008, 87(12):13291335.
41. Randeva HS, Lewandowski KC, Drzewoski J, Brooke-Wavell K, O'Callaghan C,
Czupryniak L, Hillhouse EW, Prelevic GM: Exercise decreases plasma total
homocysteine in overweight young women with polycystic ovary
syndrome. J Clin Endocrinol Metab 2002, 87(10):44964501.
42. Errington-Evans N: Acupuncture for Anxiety. CNS Neurosci Ther 2012,
18(4):277284.
43. Sato A, Sato Y, Schmidt RF: The Impact of Somatosensory Input on
Autonomic Functions. Heidelberg: Springer-Verlag; 1997.
44. Snel M, Sleddering MA, Vd Peijl ID, Romijn JA, Pijl H, Edo Meinders A, Jazet
IM: Quality of life in type 2 diabetes mellitus after a very low calorie diet
and exercise. Eur J Intern Med 2012, 23(2):143149.
45. Herring MP, Puetz TW, OConnor PJ, Dishman RK: Effect of exercise training
on depressive symptoms among patients with a chronic Illness: a
systematic review and meta-analysis of randomized controlled trials.
Arch Intern Med 2012, 172(2):101111.
46. Stener-Victorin E, Baghaei F, Holm G, Janson PO, Olivecrona G, Lonn M,
Manneras-Holm L: Effects of acupuncture and exercise on insulin
sensitivity, adipose tissue characteristics, and markers of coagulation
and fibrinolysis in women with polycystic ovary syndrome: secondary
analyses of a randomized controlled trial. Fertil Steril 2012, 97(2):501508.
doi:10.1186/1472-6882-13-131
Cite this article as: Stener-Victorin et al.: Acupuncture and physical
exercise for affective symptoms and health-related quality of life in
polycystic ovary syndrome: secondary analysis from a randomized
controlled trial. BMC Complementary and Alternative Medicine 2013 13:131.

Submit your next manuscript to BioMed Central

and take full advantage of:
Convenient online submission
Thorough peer review
No space constraints or color gure charges
Immediate publication on acceptance
Inclusion in PubMed, CAS, Scopus and Google Scholar
Research which is freely available for redistribution
Submit your manuscript at
www.biomedcentral.com/submit